Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 15 (4), 264-76

[Gastrointestinal Hormones. I. Hormones of the Gastrin Group]

[Article in German]
  • PMID: 871064

[Gastrointestinal Hormones. I. Hormones of the Gastrin Group]

[Article in German]
W P Fritsch et al. Z Gastroenterol.

Abstract

Gastrin is a peptide hormone originating from G-cells of the antrum, the duodenum and the proximal jejunum. From extracts of gastrinomas and from sera of hypergastrinaemic subjects several gastrin molecules could be isolated which were nominated as "mini gastrin" (G13), "little gastrin" (G17), "big gastrin" (G34) and "big big gastrin". Antisera used for radioimmunological gastrin determinations should be characterized with respect to their specificity, as differeing affinity towards the various gastrins and towards CCK-PZ influences the results of the assay and thus the comparability with values of other laboratories. Gastrin is released by direct vagal stimulation of the antral G-cells and by local chemical and physical stimuli in the antrum and duodenum; probably an oxynto-pyloric reflex also exists. Gastrin stimulates in physiologic doses gastric acid secretion and, as shown in dogs and cats, reveals a trophic action on parietal cell growth. H+-secretion and gastrin release are connected by a feed back mechanism, insofar, as a decrease of intragastric pH below 3 inhibits endogenous gastrin release. Hypergastrinaemia has been demonstrated in patients with gastric anacidity or hypo-secretion, benigne pyloric stenosis, uraemia, short bowel-syndrome, gastric and duodenal ulceration and in patients with gastrinomas (Zollinger-Ellison-syndrome). Hypergastrinaemia in combination with hypersecretion exhibits clinical significance in patients suffering from Zollinger-Ellison-syndrome or excluded antrum syndrome which are due to autonomous gastrin release. The differential diagnosis between these syndromes and other diseases, in which hypergastrinaemia is not associated with gastric hypersecretion, can be achieved by several tests using calcium infusion or intravenous application of secretin and glucagon. The significance of elevated gastrin levels in patients with duodenal ulceration (DU) is pointed out. In DU-patients basal and postprandial hypergastrinaemia has been observed. In these patients gastrin release from gastric and extragastric sites is increased. In these patients hypergastrinaemia due to extragastric gastrin release could cause gastric hypersecretion at a time, when the stomach already has emptied. Furthermore parietal cell hyperplasia could be the result of chronic hypergastrinaemia.

Similar articles

  • [Gastrin]
    WP Fritsch. Z Gastroenterol 16 (5), 284-93. PMID 654384.
    Gastrin antisera were raised by immunization of rabbits or guinea pigs with synthetic human gastrin I conjugated to bovine serum albumin by carbodiimide. Radioiodination …
  • Gastrin
    HT Debas. Clin Invest Med 10 (3), 222-5. PMID 3304752. - Review
    Gastrin is the most important peptide in the regulation of gastric acid secretion. This communication reviews important new developments in our knowledge of its synthesis …
  • Pathological Acid Secretion Not Due to Gastrinoma
    JH Walsh et al. Scand J Gastroenterol Suppl 82, 45-58. PMID 6579627. - Case Reports
    There are few detailed studies of patients with pathological hypergastrinaemia of antral origin. We have identified four patients with severe acid hypersecretion associat …
  • Physiology and Pathology of Gastrin
    JH Walsh et al. Clin Gastroenterol 9 (3), 567-91. PMID 7000395. - Review
    Gastrin release does play a part in the cephalic phase of acid secretion in man and is the major mechanism for the gastric phase of acid secretion. The vagal control of g …
  • Cholecystokinin in the Control of Gastric Acid and Plasma Gastrin and Somatostatin Secretion in Healthy Subjects and Duodenal Ulcer Patients Before and After Eradication of Helicobacter Pylori
    JW Konturek. J Physiol Pharmacol 45 (4 Suppl 1), 3-66. PMID 7787215. - Review
    In healthy subjects, MSF increased gastric acid outputs to about 36% of p-gastrin maximum and treatment with loxiglumide failed to affect this secretion. Standard meal en …
See all similar articles

Publication types

Feedback